FTXH vs. PPH
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and PPH (VanEck Pharmaceutical ETF) are both Health & Biotech Equities funds - FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index while PPH tracks the MVIS US Listed Pharmaceutical 25 Index. Both are passively managed. Over the past 5 years, FTXH returned 8.39%/yr vs 9.48%/yr for PPH. A 0.72 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.36%/yr for PPH.
Performance
FTXH vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 8.95% return, which is significantly higher than PPH's 1.11% return.
FTXH
- 1D
- 1.27%
- 1M
- 2.75%
- YTD
- 8.95%
- 6M
- 7.56%
- 1Y
- 42.53%
- 3Y*
- 12.47%
- 5Y*
- 8.39%
- 10Y*
- —
PPH
- 1D
- 0.92%
- 1M
- -1.45%
- YTD
- 1.11%
- 6M
- 1.61%
- 1Y
- 21.33%
- 3Y*
- 11.87%
- 5Y*
- 9.48%
- 10Y*
- 8.33%
FTXH vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 8.95% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
PPH VanEck Pharmaceutical ETF | 1.11% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between FTXH and PPH is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.86 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.82 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2016 | 0.73 |
The correlation between FTXH and PPH shifts across timeframes, from 0.72 (all time) to 0.86 (1 year), reflecting how their relationship changes across market environments.
FTXH vs. PPH - Sectors Allocation Comparison
Sectors
FTXH
PPH
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FTXH
PPH
Basic Materials
FTXH
-
PPH
-
Communication Services
FTXH
-
PPH
-
Consumer Cyclical
FTXH
-
PPH
-
Consumer Defensive
FTXH
-
PPH
-
Energy
FTXH
-
PPH
-
Financial Services
FTXH
-
PPH
-
Industrials
FTXH
-
PPH
Real Estate
FTXH
-
PPH
-
Technology
FTXH
-
PPH
-
Utilities
FTXH
-
PPH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. PPH — Risk / Return Rank
FTXH
PPH
FTXH vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FTXH | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.27 | ||
| Sortino ratioReturn per unit of downside risk | +1.75 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.22 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 5.72 | 1.99 | +3.73 |
| Martin ratioReturn relative to average drawdown | 16.84 | 4.86 | +11.98 |
Loading charts...
Drawdowns
FTXH vs. PPH - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for FTXH and PPH.
Loading charts...
Drawdown Indicators
| FTXH | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -51.45% | +19.34% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -10.76% | +3.29% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -18.06% | -1.45% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -20.26% | +0.75% |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.70% | — |
Current DrawdownCurrent decline from peak | -0.74% | -6.61% | +5.87% |
Average DrawdownAverage peak-to-trough decline | -5.81% | -17.29% | +11.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.53% | 4.40% | -1.87% |
Volatility
FTXH vs. PPH - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.36%, while VanEck Pharmaceutical ETF (PPH) has a volatility of 6.13%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.36% | 6.13% | -0.77% |
Volatility (6M)Calculated over the trailing 6-month period | 11.98% | 12.15% | -0.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.17% | 17.61% | -0.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.37% | 15.15% | +1.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.41% | 17.01% | +1.40% |
FTXH vs. PPH - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than PPH's 0.36% expense ratio.
Dividends
FTXH vs. PPH - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.18%, less than PPH's 2.08% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.18% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
PPH VanEck Pharmaceutical ETF | 2.08% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
FTXH and PPH have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PPH has higher volatility (6.13%) compared to FTXH (5.36%). In terms of maximum drawdown, FTXH dropped -32.11% vs PPH's -51.45%.
On 5-year performance, PPH leads with 9.48% vs 8.39% for FTXH. On fees, PPH is cheaper at 0.36% per year. On volatility, FTXH has been the lower-risk option at 5.36%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, PPH has performed better with a 9.48% return vs 8.39%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.60% for FTXH.
PPH has the higher dividend yield at 2.08%, compared with 1.18% for FTXH.
FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: First Trust and VanEck. Their fees differ too: 0.60% for FTXH and 0.36% for PPH.
FTXH currently has the higher Sharpe Ratio (2.49 vs 1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer